CAS: 2266569-73-5

UMB298

UMB298 is a potent and selective CBP/P300 bromodomain inhibitor. UMB298 inhibits BRD4 with IC50 of 5193nM.

UMB298 is a potent inhibitor of human xylose kinase, which is a key enzyme involved in the metabolism of d-xylose. This compound has shown promising results in inducing apoptosis and inhibiting the growth of cancer cells. UMB298 has been studied extensively for its potential as an anticancer agent, particularly in Chinese hamster ovary cells and human urine tumor cell lines. It has also been found to inhibit other kinases, including protein kinase C and casein kinase II, which may contribute to its anticancer activity. Overall, UMB298 shows great potential as a targeted therapy for cancer treatment.